Browse / AOD9604
HGH fragment 176–191
AOD9604 is a modified C-terminal fragment of hGH (residues 176–191) developed to isolate metabolic actions from the full hormone’s IGF-1 growth effects. Clinical lipolysis programs did not lead to a widely marketed drug. All catalog material is for laboratory research use only.
hGH C-terminal fragment, Lipolysis-focused design, Limited late-stage success
The fragment is studied for lipolytic and anti-lipogenic signaling without the full GH receptor’s growth program — results in humans were modest relative to early hopes.
HGH fragment 177–191 (17 aa; lipolytic domain of human growth hormone)
Several formulations were tested.
Age verification
The products on this website are only for research professionals of 21+ years of age, purchasing for research purposes only. Any human or animal consumption is strictly prohibited.
Research Use Only — not for human or animal consumption.
You must be at least 21 years old to enter this website. Please leave and return when you meet the age requirement.